Ironwood Pharmaceuticals Presents Gastrointestinal Disease Research At Digestive Disease Week 2015

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that the company and its collaborators will present data from two gastrointestinal disease research programs during Digestive Disease Week® (DDW) 2015 in Washington, D.C., May 16 through May 19, 2015. The presentations include data from multiple studies of linaclotide and IW-9179, both of which are guanylate-cyclase-C agonists, a mechanism of action pioneered by Ironwood scientists.

Help employers find you! Check out all the jobs and post your resume.